MicroRNA 548aj-2 (MIR548AJ2)

MicroRNA 548aj-2 (MIR548AJ2) is a predicted human microRNA gene belonging to the large, primate-specific miR-548 family of small non-coding RNAs that regulate gene expression at the post-transcriptional level by binding to target mRNAs and inducing their degradation or inhibiting their translation[3][6]. The miR-548 family is derived from repetitive genomic elements and is characterized by poor evolutionary conservation and heterogeneity in sequence and putative function[1]. While certain family members (such as miR-548j, miR-548k, or miR-548d-3p) have been experimentally linked to cancer-related processes such as metastasis and cell migration[1][5], there are currently no direct experimental data or established disease associations, drug interactions, or biomarker uses specific for MIR548AJ2/hsa-mir-548aj-2. It is annotated as a non-coding RNA gene without evidence for being a therapeutic target or direct pathophysiological role in disease[3][6].

Other names

hsa-mir-548aj-2MIR548AJ2microRNA 548aj-2

Not applicable (no known drugs directly targeting MIR548AJ2)